Capricor Therapeutics Inc (CAPR)

[knrorrel]

may $10+ today ? a BEAST starts 04-29-2020;
big time play now,huge reporting; U.S. FDA Approves Company’s Expanded [04-29-2020] Access Protocol to Treat Additional Patients

https://finance.yahoo.com/news/capricor-data-reports-100-percent-131510422.html

LOS ANGELES, April 29, 2020 (GLOBE NEWSWIRE)
-- Capricor Therapeutics (“Capricor”) (CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, announced today new data reporting 100 percent survival in critical COVID-19 patients who were treated with Capricor’s lead asset,
off-the-shelf (“allogeneic”) cardiac cell therapy CAP-1002, at Cedars-Sinai Medical Center as part of six compassionate care cases.

Over the course of one month, six critically ill COVID-19 patients,
all suffering from acute respiratory distress syndrome (ARDS) and
five of whom were on mechanical ventilatory support,
were safely treated with CAP-1002. Of the six patients treated,
four of them have been discharged.

Following a review of the available data, the U.S. Food and Drug Administration (FDA) approved the Company’s expanded access protocol
to treat up to 20 additional COVID-19 patients.

There is also a randomized, placebo-controlled trial planned to
treat patients with moderate and severe disease which is intended
to be funded by non-equity capital.

In the compassionate care cases, five male patients and one female patient (between ages 19 and 75)


suffering from COVID-19 received IV infusions of 150 million
allogeneic cardiosphere-derived cells (CAP-1002)..........